Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
The researchers also noted that the findings do not represent the views of the Department of Veterans Affairs or the U.S
35 Without this stimulus, especially during a calorie deficit potentially exacerbated by GLP-1 effects, the body may be less efficient at utilizing dietary protein for muscle maintenance, leading to greater lean mass loss
Y., Yin, H., Hillaire-Buys, D., Barkun, A., & Azoulay, L
More real world data suggests that GLP-1 drugs, which are reputed to aid the bodys cancer killing cells, may reduce the risk of colorectal, prostate, and liver cancer, too, says Drucker
392: s325 DOI: 10.1136/bmj.s325 Cite This Page : ScienceDaily